T1	condition 66 85	wound complications
T2	intervention 243 254	anisodamine
T3	intervention 259 278	Salvia miltiorrhiza
T4	No-of-participants 338 344	Ninety
T5	eligibility 345 396	patients undergoing mastectomy for breast carcinoma
T6	control 446 464	routine wound care
T7	outcome-Measure 596 606	Skin flaps
T8	outcome 834 864	rate of ischaemia and necrosis
T9	intervention-value 967 971	6·80
T10	control-value 979 984	23·38
T11	intervention-value 1001 1005	3·76
T12	control-value 1013 1018	23·38
T13	outcome 1051 1113	improvement in groups 2 and 3 continued to postoperative day 8
T14	intervention-value 1203 1207	1·82
T15	intervention-value 1215 1219	6·92
T16	outcome 1250 1274	volume of wound drainage
T17	outcome 1329 1357	incidence of adverse effects
T18	outcome 1452 1465	complications
